| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/31/2004 | EP1402017A1 Random gene unidirectional antisense library |
| 03/31/2004 | EP1402015A2 A soluble complex comprising a retroviral surface glycoprotein |
| 03/31/2004 | EP1402001A2 Anti-microbial peptides and compositions |
| 03/31/2004 | EP1401999A2 B7 related protein-2 molecules and uses thereof |
| 03/31/2004 | EP1401918A2 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/31/2004 | EP1401870A2 Antibodies against tumor necrosis factor delta (april) |
| 03/31/2004 | EP1401867A2 Mycobacterial antigens expressed under low oxygen tension |
| 03/31/2004 | EP1401865A2 Pathogenic and commensal vaccine antigens |
| 03/31/2004 | EP1401859A2 Chimeric flavivirus vectors |
| 03/31/2004 | EP1401836A1 Imidazo[1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 03/31/2004 | EP1401834A1 New derivatives of oxazolidinones as antibacterial agents |
| 03/31/2004 | EP1401830A2 Quinazolinediones as antibacterial agents |
| 03/31/2004 | EP1401829A1 Novel heterocyclic antibacterial compounds |
| 03/31/2004 | EP1401828A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 03/31/2004 | EP1401826A1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
| 03/31/2004 | EP1401825A2 Thiophene derivatives as antiviral agents for flavivirus infection |
| 03/31/2004 | EP1401818A2 Targeted multivalent macromolecules |
| 03/31/2004 | EP1401817A1 Isoquinoline compounds having antiinfective activity |
| 03/31/2004 | EP1401506A2 Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
| 03/31/2004 | EP1401493A1 Subunit vaccines and processes for the production thereof |
| 03/31/2004 | EP1401492A1 Ltb4 as vaccine adjuvant |
| 03/31/2004 | EP1401490A1 Tsg101 as inhibitor of hiv production |
| 03/31/2004 | EP1401489A2 Capsular polysaccharide solubilisation and combination vaccines |
| 03/31/2004 | EP1401488A1 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| 03/31/2004 | EP1401485A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 4-(2- 4-methane sulfonyl oxyphenyl ethoxy)phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and insulin |
| 03/31/2004 | EP1401484A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 03/31/2004 | EP1401483A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases |
| 03/31/2004 | EP1401478A2 Antimicrobial peptides |
| 03/31/2004 | EP1401473A2 Transporters comprising spaced arginine moieties |
| 03/31/2004 | EP1401470A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 03/31/2004 | EP1401469A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways |
| 03/31/2004 | EP1401465A2 Pharmaceutical composition for the treatment of viral infection |
| 03/31/2004 | EP1401461A2 Selective cox-2 inhibition from edible plant extracts |
| 03/31/2004 | EP1401458A2 Composition consisting of phy906 and chemotherapeutic agents |
| 03/31/2004 | EP1401457A1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1401440A1 Methods of use of fluoroquinolone compounds against bacteria |
| 03/31/2004 | EP1401436A1 Thiazolyl amides and their use as antiviral drugs |
| 03/31/2004 | EP1401435A1 Topical application of thiazolyl amides |
| 03/31/2004 | EP1401427A2 Non-peptide gnrh agents, pharmaceutical compositions and methods for their uses, and processes for preparing them |
| 03/31/2004 | EP1401422A2 Halogenated composition, method for preparing same and uses thereof |
| 03/31/2004 | EP1401421A1 Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
| 03/31/2004 | EP1401420A2 Perturbed membrane-binding compounds |
| 03/31/2004 | EP1401419A1 Benzenesulfonyl(thio)ureas for the treatment of septic shock and sirs |
| 03/31/2004 | EP1401407A1 Porous sponge-like cellulosic material for treatment of injuries |
| 03/31/2004 | EP1401402A2 Enhancement of oral bioavailability of non-emulsified formulation of prodrug esters with lecithin |
| 03/31/2004 | EP1401397A2 Pharmaceutical formulation having a masked taste and method for the production thereof |
| 03/31/2004 | EP1401377A2 Methods for treating cancer |
| 03/31/2004 | EP1401275A1 Antiviral composition and treatment method |
| 03/31/2004 | EP1372389A4 Virucidal compositions |
| 03/31/2004 | EP1370258A4 Peptide deformylase inhibitors |
| 03/31/2004 | EP1363623A4 Peptide deformylase inhibitors |
| 03/31/2004 | EP1305010B1 Dosage forms for treatment of oral mycoses |
| 03/31/2004 | EP1233944B1 Coupling condensation synthesis of heterocycles |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1232144B1 Novel il-8 receptor antagonists |
| 03/31/2004 | EP1210102A4 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 03/31/2004 | EP1209166B1 Novel a-500359 derivatives |
| 03/31/2004 | EP1121349B1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 03/31/2004 | EP1049484B1 Use of il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer |
| 03/31/2004 | EP1032581B1 Chemical synthesis of 6-o-alkyl erythromycin a |
| 03/31/2004 | EP1032580B1 Process for n-desmethylating erythromycins and derivatives thereof |
| 03/31/2004 | EP1021439B1 Crystalline antifungal polymorph |
| 03/31/2004 | EP0939625B1 2-cyclopenten-1-one as an inducer of hsp70 |
| 03/31/2004 | EP0877624B1 Streptococcal c5a peptidase vaccine |
| 03/31/2004 | EP0874852B1 Oxazolidinone antibacterial agent with tricyclic substituents |
| 03/31/2004 | EP0871439B1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 03/31/2004 | EP0858343B1 Continuous low-dose cytokine infusion therapy |
| 03/31/2004 | EP0809498B1 Pharmaceuitical composition for topical application containing acyclovir and hydrocortisone |
| 03/31/2004 | EP0796262B1 7-alkylidene cephalosporanic acid derivatives and methods of using the same |
| 03/31/2004 | EP0784677B1 Inhibitor of stem cell proliferation and uses thereof |
| 03/31/2004 | EP0772445B1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
| 03/31/2004 | EP0735818B1 MACROPHAGE INFLAMMATORY PROTEINS MIP-3, MIP-4 AND MIP-1gamma |
| 03/31/2004 | EP0656948B1 Bordetella bronchiseptica vaccine |
| 03/31/2004 | CN1486368A Methods for the production of multimeric proteins, and related compositions |
| 03/31/2004 | CN1486322A Novel carbapenem derivatives |
| 03/31/2004 | CN1486317A 1-methylcarbapenem derivatives |
| 03/31/2004 | CN1486316A Processes for the preparation of carbapenem-type antibacterial agents |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486298A Prodrugs of excitatory amino acids |
| 03/31/2004 | CN1486206A Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
| 03/31/2004 | CN1486194A Colorstrum-based composition |
| 03/31/2004 | CN1486185A Stabilized brivudine topical formulations containing metal oxide pigments |
| 03/31/2004 | CN1485343A Production method of specific IgY for venereal disease and its combined preparation |
| 03/31/2004 | CN1485326A Process for preparing berberine sulphate |
| 03/31/2004 | CN1485084A A reducing fever anti-cold medicine combination and the preparation process thereof |
| 03/31/2004 | CN1485071A Medicine for curing hydrocephalus, brain abscess and brain tumor and preparation process thereof |
| 03/31/2004 | CN1485060A Pungent and fragrant anti-rheum pillow |
| 03/31/2004 | CN1485043A Adetphos sodium chloride injection and its preparation method |
| 03/31/2004 | CN1485038A Fibrauretine powder and injection preparation |
| 03/31/2004 | CN1485035A Antiseptic composition of mezlocillin |
| 03/31/2004 | CN1485034A Rifaximin suspension mix granule formulation |
| 03/31/2004 | CN1485033A Rifaximin capsule |
| 03/31/2004 | CN1485027A Liposome anti-fungus medication sprayer formulation |
| 03/31/2004 | CN1143853C Preparing method for anti-viral compounds |
| 03/31/2004 | CN1143851C Penicillene compounds and derivatives therefrom |
| 03/31/2004 | CN1143682C Medicine for treating cold and its preparing process |
| 03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |